AABM News Roundup: October 2021 NYT explores the first instance of personalized deep brain stimulation — with stimulation delivered in response to specific electrical patterns in the brain: “Twelve days after Sarah’s device was fully operational in August 2020, her score on a standard depression scale dropped to 14 from 33, and several months later…

AABM News Roundup: July 2021 Synchron, a 20-person biotech firm, edged out Elon Musk’s Neuralink to win the FDA’s first approval to start human trials for its brain chip. The early feasibility study of their flagship product, Stentrode, will attempt to give paralyzed patients control over a digital interface using their thoughts only. “Synchron’s north…

AABM News Roundup: April 2021 Lead Stories: April 2021 There’s a growing focus on equity across the entire healthcare field. In neuromodulation, unfortunately, disparities are emerging in access to deep brain stimulation (DBS) therapy for chronic pain. …

AABM News Roundup: March 2021 Lead Stories: March 2021 Researchers from the Feinstein Institutes and GE have discovered a potential non-pharmacological treatment for diabetes and obesity: ultrasound stimulation of the liver. Studies on mice are promising, as explained by one of the authors of the study, Sangeeta Chavan: “We have extensive data to show…

AABM News Roundup: January 2021 Lead Stories: January 2021 Chad Bouton of the Feinstein Institutes describes how his lab worked to create a completely non-invasive neural bypass system in IEEE Spectrum on January 26th: “My group’s particular quest is to crack the neural codes related to movement and sensation so we can develop new…

AABM News Roundup: December 2020 Lead Stories: December 2020 Researchers at Lehigh University have made an important breakthrough: physiological evidence that a pervasive neuromodulation system — a group of neurons that controls the way more specialized neurons function — strongly influences how a key auditory region of our brain processes sound. As R. …

AABM News Roundup: November 2020 Lead Stories: November 2020 Sky Medical Technology’s CEO, Bernard Ross, discusses how bioelectronic medicine can offer solutions to critical public health challenges in the U.K.: “Medical devices can significantly reduce NHS waiting lists by making treatment pathways much more efficient. For example, wearable bioelectronic therapy, a medical device innovation…

AABM News Roundup: October 2020 Lead Stories: October 2020 In the last month, several prominent European companies in the neuromodulation and neurostimulation space have received major investments. This influx of cash reflects the impressive growth of the field: “Devices are getting more sophisticated, and new disease indications are opening up…the technology has now reached…

AABM News Roundup: September 2020 Lead Stories: September 2020 The FDA has granted breakthrough designation to SetPoint Medical’s novel bioelectronic platform to treat rheumatoid arthritis. SetPoint’s CEO, Dr. Murthy V. Simhambhatla, hailed the regulatory clearance: “This is a significant milestone for SetPoint that will enable interactive communication with the FDA, priority regulatory review for…